M·CAM, Inc. releases Patently Obvious™ on the Intellectual Property of NuVasive, Inc.

Date:  Thu, 2010-10-28

M·CAM, Inc. releases Patently Obvious™ on the Intellectual Property of NuVasive, Inc.

CHARLOTTESVILLE, VA – October 28, 2010 –– M·CAM, Inc. released its Patently Obvious™ report today on the patent holdings of NuVasive highlighted in NuVasive Inc. v. Globus Medical Inc., Civil Action No. 1:10–cv–00849–UNA, U.S. District Court for the District of Delaware. On October 5, 2010, NuVasive, Inc. initiated a patent infringement lawsuit against Globus Medical, Inc. over Globus Medical’s LLIF lateral fusion offerings. NuVasive claims that these instruments, implants and techniques infringe on NuVasive’s XLIF intellectual property, specifically that disclosed within U.S. Patent No. 7,691,057. In fact, this is just the most current in a string of lawsuits NuVasive has levied against competitors such as Orthofix International and a counterclaim against Medtronic. These most recent assertions have only continued to bring NuVasive to the attention of a number of other market players in the space, including Medtronic.

Using the M·CAM DOORS™ software platform, the innovation space surrounding the asserted patent was examined in order to understand its strength and defensibility in the face of prior and concurrent art innovations.

M·CAM’s Patently Obvious™ is a weekly report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM, Inc. is a global, full–service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards–based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious™ report on NuVasive, Inc. can be found HERE